Sumitomo Mitsui Financial Group, Inc. (SMFG)
After hours:
| Previous close | 7.52 |
| Open | 7.51 |
| Bid | 7.50 x 28000 |
| Ask | 7.56 x 2900 |
| Day's range | 7.49 - 7.58 |
| 52-week range | 6.18 - 7.95 |
| Volume | |
| Avg. volume | 1,735,530 |
| Market cap | 51.817B |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | 6.78 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.35 (4.68%) |
| Ex-dividend date | 29 Mar 2021 |
| 1y target est | N/A |
- Zacks
Sumitomo Mitsui (SMFG) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Sumitomo Mitsui (SMFG) have what it takes? Let's find out.
- Zacks
This is Why Sumitomo Mitsui (SMFG) is a Great Dividend Stock
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Sumitomo Mitsui (SMFG) have what it takes? Let's find out.
- Bloomberg
SoftBank’s Masayoshi Son Is Now Betting on Sleep Disorder Cures
(Bloomberg) -- SoftBank Group Corp.’s Masayoshi Son has bet on everything from chip companies to office-space provider WeWork Inc., but has taken an unusual turn with his latest foray: sleep disorders.Most Read from BloombergChina Cash Flowed Through Congo Bank to Former President’s Cronies‘Pension Poachers’ Are Targeting America’s Elderly VeteransReliving the New York Subway Map DebateJapan’s Aculys Pharma LLC, backed by SoftBank’s second Vision Fund, bought the rights to develop and sell pitol
